0.62
price down icon1.90%   -0.012
after-market Handel nachbörslich: .63 0.01 +1.61%
loading
Schlusskurs vom Vortag:
$0.632
Offen:
$0.6319
24-Stunden-Volumen:
27,142
Relative Volume:
0.73
Marktkapitalisierung:
$3.61M
Einnahmen:
$14.64M
Nettoeinkommen (Verlust:
$-13.74M
KGV:
-0.0853
EPS:
-7.27
Netto-Cashflow:
$-5.04M
1W Leistung:
-5.42%
1M Leistung:
+2.34%
6M Leistung:
-4.62%
1J Leistung:
-4.32%
1-Tages-Spanne:
Value
$0.60
$0.6538
1-Wochen-Bereich:
Value
$0.60
$0.6899
52-Wochen-Spanne:
Value
$0.3611
$1.0099

Novabay Pharmaceuticals Inc Stock (NBY) Company Profile

Name
Firmenname
Novabay Pharmaceuticals Inc
Name
Telefon
510-899-8800
Name
Adresse
2000 Powell Street, Suite 1150, Emeryville, CA
Name
Mitarbeiter
86
Name
Twitter
@NovaBayPharma
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
NBY's Discussions on Twitter

Vergleichen Sie NBY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NBY
Novabay Pharmaceuticals Inc
0.62 3.68M 14.64M -13.74M -5.04M -7.27
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.16 120.29B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
554.58 60.26B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
339.80 43.10B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.89 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.94 33.09B 3.81B -644.79M -669.77M -6.24

Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2019-09-18 Eingeleitet Ladenburg Thalmann Buy
2018-07-06 Bestätigt H.C. Wainwright Buy
2017-11-15 Bestätigt Laidlaw Buy
2017-06-05 Eingeleitet ROTH Capital Buy
2017-03-27 Eingeleitet Laidlaw Buy
2017-02-06 Eingeleitet Rodman & Renshaw Buy
2016-03-07 Herabstufung Maxim Group Buy → Hold
2015-12-14 Bestätigt Maxim Group Buy
2015-04-30 Fortgesetzt Maxim Group Buy
2013-03-06 Eingeleitet Ascendiant Capital Markets Strong Buy
2008-01-03 Eingeleitet Dawson James Speculative Buy
Alle ansehen

Novabay Pharmaceuticals Inc Aktie (NBY) Neueste Nachrichten

pulisher
06:21 AM

How Resilient Is NovaBay Pharmaceuticals Inc. Stock During Economic DownturnsVolatility Analysis and Entry Risk Mapping - Newser

06:21 AM
pulisher
05:39 AM

What’s next for NovaBay Pharmaceuticals Inc. stock priceMarket Timing Strategy with Technical Filters - Newser

05:39 AM
pulisher
04:33 AM

Developing predictive dashboards with NovaBay Pharmaceuticals Inc. dataShort Term Opportunity Finder with Tools - Newser

04:33 AM
pulisher
02:21 AM

Short interest data insights for NovaBay Pharmaceuticals Inc.Downside Risk Evaluation and Stock Analysis - Newser

02:21 AM
pulisher
Jul 29, 2025

Analyzing NovaBay Pharmaceuticals Inc. with multi timeframe chartsGrowth Projection Summary for Long-Term Investors - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Market reaction to NovaBay Pharmaceuticals Inc.’s recent newsLong-Term Investment Strategy Impact Analysis - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Using Ichimoku Cloud for NovaBay Pharmaceuticals Inc. technicalsFree Accurate Technical Trend Reversal Picks - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

NovaBay Pharmaceuticals Inc. Price Targets Raised After ReboundFast Gaining Stock Screener Reports Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Why NovaBay Pharmaceuticals Inc. stock attracts strong analyst attentionEntry Optimization Guide with Volume Analysis - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

Elliott Wave Theory Predicts Pullback in NovaBay Pharmaceuticals Inc.Weekly Return Pick Forecast Reports Show Trend - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What makes NovaBay Pharmaceuticals Inc. stock price move sharplyBreakthrough stock performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Using data tools to time your NovaBay Pharmaceuticals Inc. exitExpert-Backed High Yield Stock Watchlist - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

When is NovaBay Pharmaceuticals Inc. stock expected to show significant growthEarnings Report Ideas With High Returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why NovaBay Pharmaceuticals Inc. stock attracts strong analyst attention Pattern Recognition Based Market Move Prediction - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Short interest data insights for NovaBay Pharmaceuticals Inc. Free Short Term Buy Zone Stock Alerts - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

Should I hold or sell NovaBay Pharmaceuticals Inc. stock in 2025Capitalize on emerging industry trends - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is NovaBay Pharmaceuticals Inc. stock overvalued or undervaluedGet timely alerts on top market movers - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What institutional investors are buying NovaBay Pharmaceuticals Inc. stockAchieve superior capital gains with smart trades - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does NovaBay Pharmaceuticals Inc. compare to its industry peersBreakthrough profit margins - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Buy Signal for NovaBay Pharmaceuticals Inc. Stock Key Technical Indicators to WatchHigh Probability Setups - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

When is the best time to buy NovaBay Pharmaceuticals Inc. stockDaily Volume Leaders - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Is NovaBay Pharmaceuticals Inc. a good long term investmentUnmatched market gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

How NovaBay Pharmaceuticals Inc. stock reacts to Fed policy changesMarket-leading growth rates - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about NovaBay Pharmaceuticals Inc. stockFree Market Dynamics Reports - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

NovaBay Pharmaceuticals Inc. Stock Analysis and ForecastUnbelievable profit margins - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 23, 2025

What drives NovaBay Pharmaceuticals Inc. stock priceFree Investment Risk Control - Autocar Professional

Jul 23, 2025

Finanzdaten der Novabay Pharmaceuticals Inc-Aktie (NBY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.55
price up icon 0.23%
$37.12
price down icon 0.40%
$105.18
price up icon 0.17%
$26.66
price down icon 0.30%
$110.05
price down icon 1.28%
biotechnology ONC
$299.94
price down icon 1.90%
Kapitalisierung:     |  Volumen (24h):